Merck & Co., Inc. (MRK)
111.01
+2.75
(+2.54%)
USD |
NYSE |
Jan 14, 16:00
110.90
-0.11
(-0.10%)
After-Hours: 20:00
Merck EPS Diluted (Quarterly): 2.316 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Gilead Sciences, Inc. | 2.434 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Cidara Therapeutics, Inc. | -3.096 |
| Moderna, Inc. | -0.5128 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.787B |
| Revenue (Quarterly) | 17.18B |
| Total Expenses (Quarterly) | 11.40B |
| Enterprise Value | 298.71B |
| Gross Profit Margin (Quarterly) | 75.59% |
| Profit Margin (Quarterly) | 33.68% |
| Earnings Yield | 6.81% |
| Operating Earnings Yield | 9.09% |
| Normalized Earnings Yield | 7.694 |